TheraCryf PLC (TCF)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.21p
Buy
0.22p
0.002p (+0.93%)
Prices updated at 02 Jul 2026, 16:25 BST
| Prices minimum 15 mins delay
Prices in GBX
TheraCryf PLC is a biotechnology company developing new medicines for addiction and other neuropsychiatric disorders, areas of unmet medical need within central nervous system (CNS) disorders. The Group's main programme is a novel, benchmark orexin-1 ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
26 May 202615 May 202615 May 202614 May 202616 Apr 202614 Apr 202626 Jan 202605 Jan 202618 Dec 202503 Dec 2025
Key dates
| Forecast date | |
|---|---|
| Half yearly results | Dec 2026 |
| Annual general meeting | Jul 2026 |
| Annual report | Jul 2026 |
| Final results | Jul 2026 |
| Previous date | |
|---|---|
| Half yearly results | Dec 2025 |
| Annual general meeting | Jul 2025 |
| Annual report | Jun 2025 |
| Final results | Jun 2025 |
Company reports
31 Mar 2023
Annual Report 30 Sep 2025
Quarterly Report 